✦ LIBER ✦

Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis

✍ Scribed by Chandran, V.; Shen, H.; Pollock, R. A.; Pellett, F. J.; Carty, A.; Cook, R. J.; Gladman, D. D.

Book ID: 125447449
Publisher: Journal of Rheumatology Publishing Company
Year: 2013
Tongue: English
Weight: 119 KB
Volume: 40
Category: Article
ISSN: 0315-162X
DOI: 10.3899/jrheum.121162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of psoriatic arthritis and pso

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab

✍ Edmund Cauza; Marita Spak; Karla Cauza; Ursula Hanusch-Enserer; Attila Dunky; Er 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 230 KB

Efficacy of methotrexate and tumor necro

Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis

✍ Mori, Yu; Kuwahara, Yoshiyuki; Chiba, Shinpei; Itoi, Eiji 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 186 KB

Tumor Necrosis Factor- Inhibitor Use Is

Tumor Necrosis Factor- Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis

✍ BILI, A.; MORRIS, S. J.; SARTORIUS, J. A.; KIRCHNER, H. L.; ANTOHE, J. L.; DANCE 📂 Article 📅 2012 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 302 KB

Disease Activity Improvement in Rheumato

Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor- Inhibitors Correlates with Increased Soluble Fas Levels

✍ Romano, E.; Terenzi, R.; Manetti, M.; Peruzzi, F.; Fiori, G.; Nacci, F.; Belland 📂 Article 📅 2014 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 166 KB

Association of persistence with anti–tum

Association of persistence with anti–tumor necrosis factor (anti-TNF) therapy and healthcare costs in patients with psoriatic arthritis (PSA)

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long Term Costs and Outcomes in Psoriati

Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

✍ Cortesi, P.A.; Olivieri, I.; de Portu, S.; Salvarani, C.; Cauli, A.; Lubrano, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB